Home Latest News Seminars Axel Schulz: Severe COVID‐19 is characterized by an increased induction of peripheral plasmablasts with an aberrant CD62L+ HLA‐DRlow phenotype
26
Oct 21

Axel Schulz: Severe COVID‐19 is characterized by an increased induction of peripheral plasmablasts with an aberrant CD62L+ HLA‐DRlow phenotype

Event date

Tuesday, 26 October 2021 || Time: 9:15


Delineation

Hybrid: in seminar room 1 and via Zoom
This is an online event in English.
Access data will be sent after registration.
Doctoral researchers and postdocs present their research projects in the scientific context.


Event venue

Deutsches Rheuma-Forschungszentrum Berlin (DRFZ)
Charitéplatz 1
For Visitors: Virchowweg 12, Charité Campus Mitte
10117 Berlin (Mitte)
Seminarraum 1+2 (ground floor)


Click here to download the map from Google Maps


Registration & Contact

Dr. Elke Luger
instituteseminar@drfz.de

You can find our data security policy for the use of Zoom at the DRFZ here:

https://www.drfz.de/zoom-datenschutzhinweise-fuer-online-meetings-telefonkonferenzen-und-webinare/

Print
Share
Sign up for the
DRFZ NewsFlash